This medications safety profile has not been studied in patients under the age of 18, pregnant and lactating people, or those with normal BMIs. At the time of publishing, the FDA has only approved three GLP-1 agonists for weight loss: Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide)
However, compared to anemia, the evidence for riboflavin supplementation to treat preeclampsia is limited, as recently reviewed 112
Rybelsus is a daily tablet, but its not as simple as swallowing a pill with breakfast
The single most useful thing you can do before your visit: weigh yourself, measure your waist, and write down everything you take prescriptions, OTC, and supplements